The antipsychotic drug haloperidol was no more effective than placebo in treating delirium in critically ill patients, according to a study in The Lancet Respiratory Medicine. Researchers tracked 141 seriously ill patients and found that the drug had no effect on length of delirium. Haloperidol also failed to cut death rates, time on ventilators or duration of hospitalization.
Delirium drug may not benefit critically ill patients, study finds
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan